Moscow, Russia

Petr Vladimirivich Davidenko

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 11.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2016

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Petr Vladimirivich Davidenko: A Journey in Pharmaceutical Inventions

Introduction: Petr Vladimirivich Davidenko is a notable inventor based in Moscow, Russia, recognized for his contributions to the field of pharmaceuticals. With three patents to his name, he has made significant strides in developing innovative solutions for medical applications.

Latest Patents: Davidenko's latest patents focus on piperidine/piperazine derivatives, specifically as DGAT inhibitors. These inventions hold promise for various therapeutic uses, demonstrating complex chemical formulas and innovative approaches to drug development. His work includes methods for preparing these compounds and formulating pharmaceutical compositions that leverage their medicinal properties.

Career Highlights: Currently, Davidenko is associated with Janssen Pharmaceutica NV, a leading company in pharmaceutical research. His tenure there has seen fruitful innovations that address critical health challenges through novel medicinal formulations. His three patents established him as a key player in the pharmaceutical industry.

Collaborations: Throughout his career, Davidenko has collaborated with distinguished colleagues, including Joannes Theodorus Maria Linders and Lieven Meerpoel. These partnerships have facilitated the exchange of ideas and contributed to the advancement of their collective research endeavors.

Conclusion: Petr Vladimirivich Davidenko continues to inspire with his innovative approaches in pharmaceuticals. His work exemplifies how creativity and research can converge to lead to impactful inventions in the medical field. As he advances in his career, the scientific community watches with anticipation for the future breakthroughs he may produce.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…